NEW YORK (GenomeWeb) – Qiagen has terminated a project with HTG Molecular Diagnostics that is part of a multi-project assay development agreement between the companies, HTG said today in a filing with the US Securities and Exchange Commission.
NEW YORK (GenomeWeb) – Qiagen has terminated a project with HTG Molecular Diagnostics that is part of a multi-project assay development agreement between the companies, HTG said today in a filing with the US Securities and Exchange Commission.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.